Therefore, higher positive rates of serum CEA, AFP and CA19-9 in the middle-aged patients of our present study may be a result of the higher proportion of larger tumor size, T4 status and upper third tumors in middle-aged group. The gene discussed is CEACAM5; the disease is neoplasm.